| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-05 | Capps Kathleen S. See Remarks | Sale | -323 | -3.71%8,377 | $14.23 | $4,596 | View SEC filing | |
| 2025-12-05 | Trout Harry R. III See Remarks | Sale | -542 | -3.21%16,348 | $14.23 | $7,713 | View SEC filing | |
| 2025-12-05 | Rottinghaus Scott T. Chief Medical Officer | Sale | -798 | -3.53%21,792 | $14.23 | $11,356 | View SEC filing | |
| 2025-12-05 | Luu Brendan Chief Business Officer | Sale | -1,394 | -3.51%38,329 | $14.23 | $19,837 | View SEC filing | |
| 2025-12-05 | Kieffer Tara Lynn Chief Product Strategy Officer | Sale | -2,106 | -6.44%30,620 | $14.23 | $29,968 | View SEC filing | |
| 2025-12-05 | Or Yat Sun Chief Scientific Officer | Sale | -2,390 | -0.64%371,392 | $14.23 | $34,010 | View SEC filing | |
| 2025-12-05 | Luly Jay R. President and CEO | Sale | -4,743 | -0.55%858,026 | $14.23 | $67,493 | View SEC filing | |
| 2025-12-03 | Capps Kathleen S. See Remarks | Sale | -207 | -2.32%8,700 | $13.96 | $2,890 | View SEC filing | |
| 2025-12-03 | Trout Harry R. III See Remarks | Sale | -380 | -2.20%16,890 | $13.96 | $5,305 | View SEC filing | |
| 2025-02-12 | Luly Jay R. President and CEO | Purchase | +45,000 | +5.61%846,638 | $5.69 | $256,050 | View SEC filing | |
| 2024-12-10 | Kieffer Tara Lynn Chief Product Strategy Officer | Sale | -2,283 | -7.23%29,305 | $8.06 | $18,401 | View SEC filing | |
| 2024-12-10 | Luu Brendan Chief Business Officer | Sale | -2,283 | -5.96%36,047 | $8.06 | $18,401 | View SEC filing | |
| 2024-12-10 | Rottinghaus Scott T. Chief Medical Officer | Sale | -866 | -4.61%17,918 | $8.06 | $6,980 | View SEC filing | |
| 2024-12-10 | Or Yat Sun Chief Scientific Officer | Sale | -2,591 | -0.70%369,109 | $8.06 | $20,883 | View SEC filing | |
| 2024-12-10 | MELLETT PAUL J Chief Fin. & Admin Officer | Sale | -2,591 | -2.75%91,710 | $8.06 | $20,883 | View SEC filing | |
| 2024-12-10 | Luly Jay R. President and CEO | Sale | -5,142 | -0.64%801,638 | $8.06 | $41,445 | View SEC filing | |
| 2024-07-15 | Rottinghaus Scott T. Chief Medical Officer | Sale | -11,945 | -23.23%21,717 | $15.97 | $190,747 | View SEC filing | |
| 2024-06-17 | Kieffer Tara Lynn Chief Product Strategy Officer | Sale | -7,266 | -18.35%32,341 | $12.33 | $89,590 | View SEC filing | |
| 2023-12-15 | Vance Terry Director | Sale | -15,295 | -72.51%5,800 | $9.12 | $139,490 | View SEC filing | |
| 2023-12-06 | Luu Brendan Sr. VP, Business Dev. | Sale | -2,125 | -5.47%36,736 | $9.63 | $20,464 | View SEC filing | |
| 2023-12-06 | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | Sale | -2,125 | -5.40%37,260 | $9.63 | $20,464 | View SEC filing | |
| 2023-12-06 | Gardiner Nathaniel S. Sr. VP & General Counsel | Sale | -2,412 | -3.42%68,154 | $9.63 | $23,228 | View SEC filing | |
| 2023-12-06 | Rottinghaus Scott T. Sr. VP & CMO | Sale | -534 | -1.98%26,466 | $9.63 | $5,142 | View SEC filing | |
| 2023-12-06 | Or Yat Sun Sr. VP, R&D & CSO | Sale | -2,412 | -0.65%370,695 | $9.63 | $23,228 | View SEC filing | |
| 2023-12-06 | MELLETT PAUL J Sr. VP, Finance & Admin. & CFO | Sale | -2,412 | -2.51%93,549 | $9.63 | $23,228 | View SEC filing |
1-25 of 119
